Cargando…
Nicotine receptor partial agonists for smoking cessation
BACKGROUND: Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). This is an update of a Cochrane Review firs...
Autores principales: | Livingstone-Banks, Jonathan, Fanshawe, Thomas R, Thomas, Kyla H, Theodoulou, Annika, Hajizadeh, Anisa, Hartman, Lilian, Lindson, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169257/ https://www.ncbi.nlm.nih.gov/pubmed/37142273 http://dx.doi.org/10.1002/14651858.CD006103.pub8 |
Ejemplares similares
-
Nicotine receptor partial agonists for smoking cessation
por: Livingstone-Banks, Jonathan, et al.
Publicado: (2023) -
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
por: Theodoulou, Annika, et al.
Publicado: (2023) -
Antidepressants for smoking cessation
por: Hajizadeh, Anisa, et al.
Publicado: (2023) -
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta‐analyses
por: Lindson, Nicola, et al.
Publicado: (2023) -
Mindfulness for smoking cessation
por: Jackson, Sarah, et al.
Publicado: (2022)